Exagen, Inc. (XGN)
8.495
+0.24
(+2.97%)
USD |
NASDAQ |
Oct 13, 16:00
8.495
0.00 (0.00%)
After-Hours: 20:00
Exagen Free Cash Flow : -7.588M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.588M |
| March 31, 2026 | -14.13M |
| December 31, 2025 | -14.27M |
| September 30, 2025 | -10.99M |
| June 30, 2025 | -15.98M |
| March 31, 2025 | -15.45M |
| December 31, 2024 | -13.79M |
| September 30, 2024 | -5.768M |
| June 30, 2024 | -6.355M |
| March 31, 2024 | -14.27M |
| December 31, 2023 | -15.29M |
| September 30, 2023 | -29.67M |
| June 30, 2023 | -34.32M |
| March 31, 2023 | -36.95M |
| December 31, 2022 | -36.46M |
| September 30, 2022 | -37.43M |
| June 30, 2022 | -35.81M |
| March 31, 2022 | -27.87M |
| December 31, 2021 | -22.69M |
| September 30, 2021 | -19.48M |
| June 30, 2021 | -15.89M |
| March 31, 2021 | -15.63M |
| Date | Value |
|---|---|
| December 31, 2020 | -14.54M |
| September 30, 2020 | -14.59M |
| June 30, 2020 | -13.92M |
| March 31, 2020 | -11.19M |
| December 31, 2019 | -10.11M |
| September 30, 2019 | -8.101M |
| June 30, 2019 | -8.517M |
| March 31, 2019 | -8.331M |
| December 31, 2018 | -9.50M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2015 | -12.71M |
| September 30, 2015 | -11.65M |
| June 30, 2015 | -11.08M |
| March 31, 2015 | -10.96M |
| December 31, 2014 | -11.42M |
| September 30, 2014 | -11.32M |
| June 30, 2014 | -10.21M |
| March 31, 2014 | -8.475M |
| December 31, 2013 | -7.037M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Myriad Genetics, Inc. | -14.20M |
| BioRestorative Therapies, Inc. | -11.90M |
| CareDx, Inc. | 84.03M |
| Natera, Inc. | 51.20M |
| Sera Prognostics, Inc. | -28.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.988M |
| Cash from Investing (Quarterly) | -0.543M |
| Cash from Financing (Quarterly) | -0.37M |
| Free Cash Flow Per Share (Quarterly) | 0.1426 |
| Free Cash Flow to Equity (Quarterly) | 2.935M |
| Free Cash Flow to Firm (Quarterly) | 4.646M |
| Free Cash Flow Yield | -3.78% |